One of the biggest challenges in the IVIG market is the supply and demand imbalance of human plasma. Plasma collection is a time-intensive process, and the cost of obtaining plasma continues to rise, ...
Intravenous immunoglobin (IVIG) is a solution containing antibodies that healthcare professionals may use to treat primary immune deficiency disease (PIDD) and various other conditions. The amount ...
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, costs, and how each impacts quality of life.